Drug Database
LI

lidocaine hydrochloride (3268 / lignocaine, Anesiva / ALGRX 3268)

✓ Approved

Marathon Pharmaceuticals · SCN9A · 小分子

什么是 lidocaine hydrochloride?

lidocaine hydrochloride 是一种小分子,由Marathon Pharmaceuticals研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intradermal Injection。

药物档案

商品名3268, lignocaine, Anesiva, ALGRX 3268
公司Marathon Pharmaceuticals
药物类别小分子
分子靶点SCN9A
给药途径Injectable (Others), Intradermal Injection
状态Approved

作用机制

分子靶点

lidocaine hydrochloride 作用于 1 个分子靶点:

SCN9Asodium voltage-gated channel alpha subunit 9 (SFNP, GEFSP7)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

lidocaine hydrochloride 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Nervous system disordersAnaesthesia✓ Approved
Nervous system disordersSensory loss✓ Approved

相关研究文献

PubMedClinical oral investigations2026-11-19

Intra-sulcular compound chamomile and lidocaine hydrochloride gel for procedural pain during ultrasonic scaling: a randomized, single-blind, split-mouth, sham-controlled superiority trial in adults with plaque-induced gingivitis.

Tang Rong R, Yin Tingting T, Liang Jia J, Wang Ruijie R et al.

This study aimed to evaluate whether intra-sulcular application of a compound chamomile and lidocaine hydrochloride gel (Kami-Gel) reduces procedural pain during ultrasonic supragingival scaling in adults with plaque-induced gingivitis compared with a sham procedure. A single-center, randomized, single-blind, split-mouth, sham-controlled superiority trial was conducted involving 114 adults with plaque-induced gingivitis. Participants received a sequential split-mouth treatment. The test side received intra-sulcular application of Kami-Gel, while the control side received a sham application (mimicked injection). The primary outcome was procedural pain intensity measured on a 0-10 Visual Analog Scale (VAS). Secondary outcomes included the number of pain complaints, procedural duration, patient satisfaction, and plaque index (PI). Safety was assessed immediately and at 24 h. All 114 participants completed the study. Median VAS score was significantly lower in the test group (1.7 [IQR: 0.62-2.58]) than the control group (4.1 [IQR: 2.42-5.7]), with an estimated treatment difference of - 2.35 (95% CI: -3.0 to - 1.7)-the upper limit of which fell below the pre-specified superiority margin of - 1.2, confirming superiority (P < 0.001). The test group also demonstrated significantly fewer pain complaints (median 0 vs. 1), shorter procedural duration (median 10 vs. 12 min), and higher patient satisfaction (all P < 0.001). Post-scaling plaque index was significantly lower in the test group (median 0.75 [IQR: 0.55-0.86] vs. 0.89 [IQR: 0.75-0.96]; P < 0.001), though this difference may reflect improved patient cooperation rather than a direct pharmacological effect. No adverse events were reported. Intra-sulcular application of compound chamomile and lidocaine hydrochloride gel reduces procedural pain during ultrasonic supragingival scaling compared to a sham procedure. Its use was associated with shorter active scaling time and higher satisfaction. Whether these acute benefits translate to improved long-term periodontal treatment compliance warrants further investigation. Intra-sulcular application of compound chamomile and lidocaine gel (Kami-Gel) prior to ultrasonic supragingival scaling reduces procedural pain and was associated with higher patient satisfaction. A lower post-scaling plaque index was observed in the test group, potentially attributable to improved patient cooperation during instrumentation. This safe, non-injectable chairside technique provides clinicians a practical tool to enhance patient comfort during scaling procedures.

PMID 43052462
阅读全文 →
PubMedBMC oral health2026-11-19

Antibacterial efficacy of octenidine, sodium hypochlorite, and their combination against multispecies endodontic biofilms: an in vitro CLSM study.

Baştürk Özer Muazzez Naz MN, Çulha Emre E, Özer Hasan Yıldırım HY

The current study used confocal laser scanning microscopy (CLSM) to assess the antibacterial activity of octenidine hydrochloride (OCT) both by itself and in combination with sodium hypochlorite (NaOCl) on the eradication of biofilms. Forty dentin blocks were inoculated with a biofilm consisting of Enterococcus faecalis, Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus mutans. After a 3-week incubation period, the resulting diverse biofilm was imaged using a scanning electron microscope (SEM). Five groups were formed: Saline solution (SS), 2% chlorhexidine (CHX), 5% NaOCl, undiluted OCT (containing 0.1% octenidine), and a 5% NaOCl / undiluted OCT mixture (90:10 ratio). Samples were subjected to the relevant agent for 5 min. The percentage of dead cell bacteria was evaluated using the Live/Dead BacLight Viability Kit dye under CLSM. Image analysis was performed with Image J software. The Kruskal-Wallis and Dunn's tests were used to statistically assess the data, with a significance threshold of p < 0.05. CLSM images showed that the NaOCl alone eliminated the amount of bacteria similar to NaOCl/OCT mixture group (p > 0.05) and significantly more bacteria compared to other solutions (p < 0.05). NaOCl/OCT mixture group was also similar to the OCT alone group (p > 0.05), while CHX and SS groups represented the least amount of dead bacteria than other groups (p < 0.05). Under the experimental conditions, the NaOCl/OCT combination demonstrated antibacterial activity comparable to NaOCl alone. While 5% NaOCl remained the most effective agent, the addition of OCT did not provide a statistically significant increase in antibacterial efficacy. SS and CHX exhibited significantly lower antibacterial effects.

PMID 43052949
阅读全文 →
PubMedVestnik otorinolaringologii2026-11-18

[Possibilities of topical therapy of acute bullous otitis media].

Baranov K K KK, Vyazmenov E O EO, Kotova E N EN, Polunin M M MM et al.

Bullous myringitis is a borderline condition between inflammatory processes of the external and middle ear. The aim was to evaluate the comparative efficacy of three combined topical preparations in complex treatment of acute bullous otitis media. 140 patients aged 6-40 years (110 (78.6%) children) were divided into three groups: group 1 (n=50) - chloramphenicol+clotrimazole+beclomethasone dipropionate+lidocaine hydrochloride; group 2 (n=45) - phenazone+lidocaine; group 3 (n=45) - neomycin+polymyxin B+dexamethasone. Pain relief was fastest in group 2 (by day 3); otoscopic signs resolved by day 5, with the best combined results in group 1. In 25-28 (17.9-20.0%) patients bullous otitis was associated with PCR-confirmed influenza A (H1N1); Mycoplasma pneumoniae was detected in 4 (2.9%). The incidence peaked in December-February.

PMID 43046736
阅读全文 →
PubMedFrontiers in pharmacology2026-11-18

Lidocaine modulates interleukin-1β and interferon-α2 secretion in LPS with ATP stimulated human peripheral blood mononuclear cells.

Oostwouder Cees-Jan CJ, Vos Karin K, Merkus Mathijs R MR, Tolsma Casper S CS et al.

Local anesthetics are canonically used for analgesia and anti-arrhythmic therapy, but increasing evidence indicates additional anti-inflammatory properties, including modulation of purinergic signalling. A recent retrospective observational cohort study indicated that subcutaneous lidocaine-Hydroxypropyl-β-cyclodextrin (HP-β-CD) was associated with sustained improvements in quality of life in patients with neuropathic pain in post-COVID, but the underlying mechanism remains to be established. The aim of this study was to determine whether lidocaine and articaine, alone or in combination with HP-β-CD, modulate in vitro immune cell activation and cytokine secretion in human peripheral blood mononuclear cells (PBMCs). PBMCs were stimulated using phytohemagglutinin (PHA), lipopolysaccharide (LPS), or LPS combined with adenosine triphosphate (ATP) to engage P2X-associated inflammatory pathways, and compounds were applied both prior to and following stimulation. Cytokine secretion was quantified using a 13-plex immunoassay and cell activation was assessed by flow cytometry. Lidocaine-containing formulations attenuated cytokine secretion most prominently under conditions engaging ATP-dependent signaling, reducing interleukin-1β and interferon-α2, with interleukin-1β suppression being the most consistent effect across stimulation conditions. Articaine showed less consistent immunomodulatory effects than lidocaine, which may reflect its previously reported lack of purinergic receptor inhibition, while HP-β-CD alone did not influence immune activation or cytokine release under any condition. Together, these findings show that lidocaine-containing treatments can modulate cytokine responses in human PBMCs, particularly under LPS with ATP stimulation. These findings identify lidocaine as a modulator of ATP-dependent inflammatory signaling.

PMID 43047804
阅读全文 →
PubMedFrontiers in aging2026-11-18

Effect of papaverine hydrochloride on functional visual acuity in non-arteritic central retinal artery occlusion: a retrospective cohort study.

Liu Zhongzhong Z, Lu Qingli Q, Liu Tong T, Peng Linna L et al.

Non-arteritic central retinal artery occlusion (NA-CRAO) is an acute ocular emergency that frequently results in severe and irreversible vision loss with limited therapeutic options. Papaverine hydrochloride, a non-specific vasodilator commonly used to relieve vasospasm, has not been previously evaluated for its potential benefits for visual recovery in patients with NA-CRAO. Therefore, this study aims to investigate the association between papaverine hydrochloride treatment (PHt) and functional visual acuity improvement in patients with NA-CRAO. Propensity-score matching was used to retrospectively collect clinical data of 104 NA-CRAO patients with similar baseline characteristics. The patients were categorized into a PHt group (n = 52) and a non-papaverine hydrochloride treatment (non-PHt) group (n = 52). The primary outcome was functional visual acuity (best-corrected visual acuity ≥20/100) assessed at discharge and at a 1-month follow-up. Logistic regression and subgroup analyses were performed to evaluate the associations between papaverine hydrochloride use and improvements in functional visual acuity. The PHt group showed significantly higher functional visual acuity than the non-PHt group at discharge (32.7% vs. 15.4%, p = 0.039) and at the 1-month follow-up (53.8% vs. 34.6%, p = 0.048). In adjusted models, treatment with papaverine hydrochloride was an independent favorable factor for improved functional visual acuity at discharge (odds ratio [OR] = 3.52, 95% confidence interval [CI]: 1.20-10.36, p = 0.022) and at the 1-month follow-up (OR = 3.15, 95% CI: 1.19-8.29, p = 0.020). Subgroup analyses demonstrated consistent therapeutic effects across age, sex, the side of the affected eye, intra-arterial thrombolysis and intravenous thrombolysis strata, with no statistically significant interaction effects identified at either time point (all Pinteraction >0.05). Treatment with papaverine hydrochloride was significantly associated with visual recovery in patients with NA-CRAO. Prospective further studies of causality are needed to validate these results and assess their safety.

PMID 43047374
阅读全文 →
PubMedAdvanced healthcare materials2026-11-18

Bioadhesive Hyaluronic Acid-Cellulose Hydrogels for Sustained BDNF Release to Mitigate Local Anesthetic Neurotoxicity and Enhance Peripheral Nerve Repair.

Li Ziyou Z, Yin Wenming W, Qin Xinghui X, Bi Xinyu X et al.

Peripheral nerve block (PNB) is indispensable in regional anesthesia, yet local anesthetics such as lidocaine can provoke neurotoxicity, causing dorsal root ganglion injury and delayed nerve recovery. Although brain-derived neurotrophic factor (BDNF) is a potent neuroregenerative cue, its clinical value is limited by rapid degradation and poor local retention. Here, we report an injectable, bioadhesive hybrid covalent/dynamic hydrogel (DAHA-POMC) constructed from hyaluronic acid and cellulose for sustained BDNF delivery and peripheral nerve repair. The hydrogel exhibited rapid in situ gelation, favorable mechanics, elastic recovery, and controllable degradation, enabling prolonged retention of bioactive BDNF. In vitro, BDNF released from the DAHA-POMC hydrogel retained neurotrophic activity, and protected lidocaine-exposed dorsal root ganglion (DRG)-derived neuronal cells by improving viability, preserving mitochondrial membrane potential, reducing apoptosis, and promoting axonal outgrowth. Transcriptomic and protein analyses supported the involvement of ERK signaling in this neuroprotective effect. In vivo, in an intraneural lidocaine-associated sciatic nerve injury (SNI) model, the BDNF-loaded hydrogel significantly outperformed free BDNF, improving nerve conduction, remyelination, and gastrocnemius muscle preservation. Collectively, this work establishes DAHA-POMC as a multifunctional neuroregenerative platform that integrates localized BDNF delivery with regenerative tissue support, offering a potential post-injury treatment strategy for focal peripheral nerve injury associated with local-anesthetic exposure.

PMID 43045960
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多lidocaine hydrochloride